News
CARVYKTI® (ciltacabtagene autoleucel; cilta-cel) net trade sales of approximately $369 million <li /> Over 6,000 patients tr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback